Budget impact analysis of two different methods of evaluating EVR to peginterferon alfa-2b (PegIntron?) plus ribavirin (Rebetol) in genotype 1 naïve patients with chronic hepatitis C
55th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD). Boston, Massachusetts, EEUU. 29 oct-2 nov 2004
Buti M, Casado MA, Fosbrook L, Esteban R